Characteristics Control group (n=38) Study group
ER-negative< (n=21) ER-positive< (n=34)
Age* (Years) 37.34 ± 8.70 53.52 ± 11.98 55.26 ± 11.11
Height (Cm) 157.70 ± 5.98 154.34 ± 4.18 156.72 ± 4.43
Weight (Kg) 59.28 ± 11.74 62.55 ± 9.10 64.29 ± 11.28
BMI 24.12 ± 4.69 26.25 ± 3.69 26.08 ± 4.0
Menarche (Years) 13.57 ± 1.08 14.19 ± 1.03 14.31 ± 1.46
Menopause (Years) 44.57 ± 5.76 48.85 ± 2.28 46.76 ± 3.58
Breast feeding (Months) 27.44 ± 24.52 39.19 ± 18.65 37.88 ± 29.03
Number of children 2.15 ± 1.91 2.52 ± 0.67 2.55 ± 1.28
Lump size (Cm) 3.39 ± 1.45 4.57 ± 2.37 3.89 ± 1.89
Side of lump Left 17(44.74%) 14(66.67%) 24(70.59%)
Right 21(55.26%) 7(33.33%) 10(29.41%)
Abode Rural 2(5.26%) 2(9.52%) 4(11.76%)
Urban 36(94.74%) 19(90.48) 30(88.24)
Family history Yes 1(2.63%) 2(9.52%) 3(8.82%)
No 37(97.37%) 19(90.48%) 31(91.18%)
Menstrual status Pre 24(63.16%) 1(4.76%) 2(5.89%)
Peri 7(18.42%) 6(28.58%) 7(20.58%)
Post 7(18.42%) 14(66.66%) 25(73.53%)
Values represented as mean ± SD and %age
Kruskal-Wallis test was applied
*p<0.001.
Table 1: Characteristics of the subjects of three groups with benign breast disease (Control subjects) and breast cancer with or without estrogen receptors.